Shares of Celgene Corp. (CELG, Financial) plummeted almost 20% after the company announced its results for the third quarter on Thursday morning. It posted diluted earnings per share of $1.91, beating expectations by four cents. Revenue of $3.3 billion missed estimates by $120 million but increased 11% year over year.Â
The company reported lower-than-expected sales for one of its top drugs, Otezla, and lowered its overall 2020 sales outlook.
"Over the coming months, we look forward to sharing data supporting our innovative, next generation pipeline products and significant growth drivers,” CEO Mark J. Alles said.
Ultra Clean Holdings Inc. (UCTT)Â tanked more than 20% after the company reported third-quarter EPS of 62 cents on Wednesday afternoon, which fell two cents short of estimates. Quarterly revenue of $242.61 million beat expectations of $240 million and increased 66% year over year.
Semiconductor revenue increased 5.7% from the previous quarter and 71.8% from the year-ago quarter. Total revenue from outside the U.S. grew 11.3% sequentially and 81.6% from a year ago.
The company now expects revenue to be in the range of $240 million to $250 million and GAAP diluted net income per share to be between 54 cents and 60 cents. Non-GAAP net income per diluted share is expected to be between 57 cents and 63 cents.
Shares of Nutrisystem Inc. (NTRI, Financial) fell more than 10% on the back of the company announcing third-quarter results after the market closed Wednesday. It posted EPS of 49 cents on revenue of $158.15 million, beating expectations by three cents and $2.94 million. Revenue grew 27% year over year.
Disclosure: The author holds no positions in any stocks mentioned.
